These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30988246)

  • 21. Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.
    Biruete A; Metzger CE; Chen NX; Swallow EA; Vrabec C; Clinkenbeard EL; Stacy AJ; Srinivasan S; O'Neill K; Avin KG; Allen MR; Moe SM
    Nephrol Dial Transplant; 2022 Sep; 37(10):1857-1867. PubMed ID: 35482713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.
    Block GA; Block MS; Smits G; Mehta R; Isakova T; Wolf M; Chertow GM
    J Am Soc Nephrol; 2019 Aug; 30(8):1495-1504. PubMed ID: 31278194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renoprotective effects of ferric citrate in a mouse model of chronic kidney disease.
    Hanudel MR; Czaya B; Wong S; Jung G; Chua K; Qiao B; Gabayan V; Ganz T
    Sci Rep; 2022 Apr; 12(1):6695. PubMed ID: 35461329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study.
    Spanaus KS; Kronenberg F; Ritz E; Schlapbach R; Fliser D; Hersberger M; Kollerits B; König P; von Eckardstein A;
    Clin Chem; 2007 Jul; 53(7):1264-72. PubMed ID: 17478561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease.
    Naito Y; Fujii A; Sawada H; Oboshi M; Iwasaku T; Okuhara Y; Morisawa D; Eguchi A; Hirotani S; Masuyama T
    Hypertens Res; 2015 Jul; 38(7):463-70. PubMed ID: 25693854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a Ferric Citrate Formulation, a Phosphate Binder, on Oxidative Stress in Chronic Kidney Diseases-Mineral and Bone Disorder Patients Receiving Hemodialysis: A Pilot Study.
    Tanaka M; Miyamura S; Imafuku T; Tominaga Y; Maeda H; Anraku M; Yamasaki K; Kadowaki D; Ishima Y; Watanabe H; Okuda T; Itoh K; Matsushita K; Fukagawa M; Otagiri M; Maruyama T
    Biol Pharm Bull; 2016; 39(6):1000-6. PubMed ID: 27251502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.
    Sawada R; Hashimoto Y; Senmaru T; Tanaka M; Ushigome E; Yamazaki M; Fukui M
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):590-595. PubMed ID: 29697035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ferric citrate in the management of hyperphosphataemia and iron deficiency anaemia: A meta-analysis in patients with chronic kidney disease.
    Choi YJ; Noh Y; Shin S
    Br J Clin Pharmacol; 2021 Feb; 87(2):414-426. PubMed ID: 32470149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a prolyl hydroxylase inhibitor on kidney and cardiovascular complications in a rat model of chronic kidney disease.
    Uchida L; Tanaka T; Saito H; Sugahara M; Wakashima T; Fukui K; Nangaku M
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F388-F401. PubMed ID: 31841388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of phosphorus and PTH to the development of cardiac hypertrophy and fibrosis in an experimental model of chronic renal failure.
    Martínez-Arias L; Panizo-García S; Martín-Vírgala J; Martín-Carro B; Fernández-Villabrille S; Avello-Llano N; Miguel-Fernández D; Ruíz Torres MP; Cannata-Andía JB; Carrillo-López N; Naves-Díaz M
    Nefrologia (Engl Ed); 2021; 41(6):640-651. PubMed ID: 36165154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
    Van Buren PN; Lewis JB; Dwyer JP; Greene T; Middleton J; Sika M; Umanath K; Abraham JD; Arfeen SS; Bowline IG; Chernin G; Fadem SZ; Goral S; Koury M; Sinsakul MV; Weiner DE;
    Am J Kidney Dis; 2015 Sep; 66(3):479-88. PubMed ID: 25958079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between glomerular filtration rate and plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with chronic kidney disease.
    Miyagawa Y; Tominaga Y; Toda N; Takemura N
    Vet J; 2013 Aug; 197(2):445-50. PubMed ID: 23570775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary tetrahydrocurcumin reduces renal fibrosis and cardiac hypertrophy in 5/6 nephrectomized rats.
    Lau WL; Khazaeli M; Savoj J; Manekia K; Bangash M; Thakurta RG; Dang A; Vaziri ND; Singh B
    Pharmacol Res Perspect; 2018 Apr; 6(2):e00385. PubMed ID: 29468071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assessing Cardiac Function of Patients with Chronic Kidney Disease using N-Terminal Pro-brain Natriuretic Peptide Precursor (NT-proBNP)].
    Song HL; Yang TT; Li GX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):561-565. PubMed ID: 28752975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac remodeling associated with protein increase and lipid accumulation in early-stage chronic kidney disease in rats.
    Kuwahara M; Bannai K; Segawa H; Miyamoto K; Yamato H
    Biochim Biophys Acta; 2014 Sep; 1842(9):1433-43. PubMed ID: 24798235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interaction between N-terminal pro-brain natriuretic peptide and fluid status in adverse clinical outcomes of late stages of chronic kidney disease.
    Tsai YC; Tsai HJ; Lee CS; Chiu YW; Kuo HT; Lee SC; Chen TH; Kuo MC
    PLoS One; 2018; 13(8):e0202733. PubMed ID: 30133531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferric Citrate Supplementation Reduces Red-Blood-Cell Aggregation and Improves CD163+ Macrophage-Mediated Hemoglobin Metabolism in a Rat Model of High-Fat-Diet-Induced Obesity.
    Chang TY; Liu KL; Chang CS; Su CT; Chen SH; Lee YC; Chang JS
    Mol Nutr Food Res; 2018 Jan; 62(2):. PubMed ID: 29064631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.